Eli Lilly (LLY) PT Raised to $256 at Goldman Sachs
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,286.14 +4.93%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
Goldman Sachs analyst Terence Flynn raised the price target on Eli Lilly (NYSE: LLY) to $256.00 (from $227.00) while maintaining a Conviction Buy rating.
You May Also Be Interested In
- Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
- Morgan Stanley Upgrades Suncor Energy (SU) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
